Real-world comparative effectiveness and safety of pembrolizumab for PD-L1≥50% metastatic non-small cell lung cancer
Parmar A, Lu B, Luo J, Chan KKW. Future Oncol. 2024; May 29 [Epub ahead of print].
Parmar A, Lu B, Luo J, Chan KKW. Future Oncol. 2024; May 29 [Epub ahead of print].
Ruco A, Moineddin R, Sutradhar R, Tinmouth J, Li Q, Rabeneck L, Del Giudice ME, Dubé C, Baxter NN. 2024; May 5 [Epub ahead of print].
Tan VS, Tjong MC, Chan WC, Yan M, Delibasic V, Darling G, Davis LE, Doherty M, Hallet J, Kidane B, Mahar A, Mittmann N, Parmar A, Tan H, Wright FC, Coburn NG, Louie AV. Support Care Cancer. 2024; 32(6):381. Epub 2024 May 24.
Walsh R, Lofters A, Groome P, Moineddin R, Krzyzanowska M, Griffiths R, Grunfeld E. Cancer Causes Control. 2024; May 15 [Epub ahead of print].
Roberts A, Hallet J, Nguyen L, Coburn N, Wright FC, Gandhi S, Jerzak K, Eisen A, Look Hong NJ. Breast Cancer Res Treat. 2024; Apr 27 [Epub ahead of print].
Parvez E, Bogach J, Kirkwood D, Pond G, Doumouras A, Hodgson N, Levine M. Ann Surg Oncol. 2024; Apr 18 [Epub ahead of print].
Mian H, Seow H, Balitsky AK, Cheung MC, Gayowsky A, Tay J, Wildes TM, McCurdy A, Visram A, Sandhu I, Sutradhar R. Oncologist. 2024; Apr 18 [Epub ahead of print].
Gupta A, Nguyen P, Kain D, Robinson AG, Kulkarni AA, Johnson DH, Presley CJ, Blaes AH, Rocque GB, Ganguli I, Booth CM, Hanna TP. JAMA Netw Open. 2024; 7(4):e244278. Epub 2024 Apr 8.
Worthington J, Sun Z, Fu R, Lew JB, Chan KKW, Li Q, Eskander A, Hui H, McLoughlin K, Caruana M, Peacock S, Yong JHE, Canfell K, Feletto E, Malagón T. PLoS One. 2024; 19(4):e0296945. Epub 2024 Apr 1.
Lofters AK, Sammott SA, Swayze S, Bender JL, Alibhai SMH, Henry A, Noel K, Datta G. Cancer Epidemiol. 2024; Mar 21 [Epub ahead of print].